Results 31 to 40 of about 2,522 (211)

Predictive factors of extracorporeal shock wave lithotripsy failure in the treatment of patients with ureterolithiasis

open access: yesZaporožskij Medicinskij Žurnal, 2021
Efficacy of different approaches to the treatment in patients with ureteral calculi and predictive factors for the success are the objects of contemporary studies. However, only few on them studied the duration factor of typical ureterolithiasis symptoms
O. S. Vozianov, S. O. Vozianov
doaj   +1 more source

EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY

open access: yesThe Professional Medical Journal, 2015
Objective: To evaluate the effect of urinary calculi attenuation values fromnon enhanced computed tomography (stone radiodensity) and stone size in determiningthe outcome of treatment by ESWL. Study design: Descriptive case series study. Setting:Department of Diagnostic Radiology, Lahore General Hospital Lahore, in collaboration with theDepartment of ...
Abdul Ahad Akbar   +2 more
openaire   +2 more sources

Factors Affecting the Outcome of Extracorporeal Shockwave Lithotripsy in Urinary Stone Treatment

open access: yesOman Medical Journal, 2018
Objectives: We sought to evaluate the factors affecting the outcome of extracorporeal shockwave lithotripsy (ESWL) in urinary stone treatment. Methods: We conducted a retrospective review of 235 adult patients treated with ESWL, for radiopaque renal or ...
Sanjay Shinde   +4 more
doaj   +1 more source

EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY;

open access: yesThe Professional Medical Journal, 2008
Treatment of renal stone is always a challenge. High incidence ofrecurrence of renal stone compels the treating physician to opt for minimally invasive treatment. With the advent of extracorporeal shock wave lithotripsy the treatment has been completely revolutionized.
MUHAMMAD MUZAMMIL TAHIR   +2 more
openaire   +2 more sources

The reasons of unsatisfactory results of extracorporeal shock wave lithotripsy in patients with ureterolithiasis [PDF]

open access: yes, 2021
The article dedicate to the problem of failure of extracorporeal shockwave lithotripsy in patients with ureterolithiasis and reveal the changes which appear in the ureter in the location of the stone.The aim.
Vozianov, Oleksandr
core   +2 more sources

Comparison of clinical outcome of extracorporeal shockwave lithotripsy in patients with radiopaque v radiolucent ureteral calculi [PDF]

open access: yes, 2003
Purpose: To compare the efficacy of extracorporeal shockwave lithotripsy (SWL) in patients with radiopaque and radiolucent ureteral ...
Saglam, R   +3 more
core   +1 more source

Residual Stone Fragment after Percutaneous Nephrolithotomy; Shockwave Lithotripsy Vs Retrograde Intrarenal Surgery

open access: yesAdvanced Medical Journal
Background and objectives: The integration of technology into percutaneous nephrolithotomy procedures has yet to eliminate the issue of residual stone fragments, which cause recurrence or blockage of ureters.
Rako Abdulqader Hamarashid   +2 more
doaj   +1 more source

Extracorporeal shockwave lithotripsy: current knowledge and future perspectives [PDF]

open access: yes, 2019
Over the last four decades, extracorporeal shockwave lithotripsy (ESWL) has been used as an effective technique to treat kidney and ureteral stones.
Kartalas Goumas, Ioannis   +7 more
core   +1 more source

Extracorporeal Shockwave Lithotripsy of Gallstones

open access: yesAnnals of Surgery, 1989
Recently extracorporeal shockwave lithotripsy (ESWL) has been introduced as a nonoperative treatment for gallstone disease. Except for lung damage, no significant adverse effects of ESWL of gallbladder stones have been observed in animals. In clinical use ESWL of gallbladder stones is now confined to 15% to 30% of symptomatic patients.
H, Vergunst   +5 more
openaire   +3 more sources

Practical Recommendations for Anticoagulation in Patients With Atrial Fibrillation

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 5, May 2026.
Oral anticoagulation (OAC) reduces stroke risk by at least two thirds and mortality by one fourth. The threshold for net clinical benefit of OAC is met when stroke risk exceeds 1%–2% per year. Direct oral anticoagulants (DOACs) are preferred to vitamin K antagonists (VKAs) in most patients, including in the elderly and chronic kidney disease ...
Nicolas Johner, Baris Gencer
wiley   +1 more source

Home - About - Disclaimer - Privacy